|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | High detec- tion rate of adenomas in familial colorectal cancer 显示文摘 | van der Meulen-de Jong AE Morreau H Becx MC | 2011 | Gut2011，60，1： | 1 |
| 2 | New treatment modalities in advanced thyroid cancer显示文摘 | Kapiteijn E Schneider T Morreau H | | 0，，： | 1 |
| 3 | Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colo- rectal carcinoma) :a guide for clinicians显示文摘 | Hendriks YM de Jong AE Morreau H | 2006 | CA Cancer J Clin2006，56，： | 1 |
| 4 | Combined immunostaining with galectin-3,fibronectin-1,CITED-1,Hector Battifora mesothelial-1,cytokeratin-19,peroxisome proliferator-activated receptor-{ gamma},and sodium/iodide symporter antibodies for the differential diagnosis of nonmedullary thyroid c显示文摘 | Liu YY Morreau H Kievit J | | 0，，3： | 1 |
| 5 | No recurrence of spo radic primary hyperparathyroidism when cure is established 6 months a{ter parathyroidectomy显示文摘 | Witteveen J E Kievit J Morreau H | 2010 | Eur J Endocrinol2010，，： | 1 |
| 6 | Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative eolorectal cancer patients predict disease recurrence 显示文摘 | Doekhie F S Morreau H de Bock G H | 2008 | Cancer Microenviron2008，1，1： | 1 |
| 7 | Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells显示文摘 | Zhou XY Morreau H Rottier R | 1995 | Genes Dev1995，9，21： | 1 |
| 8 | Combined immunostaining with galectin-3, fibronectin-l, CITED-l, Hector Battifora mesothelial-1, cytokeratin- 19, peroxisome proliferator-activated receptor- {gamma}, and Sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma显示文摘 | Liu YY Morreau H Kievit J | 2008 | Eur J Endocrinol2008，158，3： | 1 |
| 9 | Combined immunostaining with galectin- 3,fibronectin-I ,CITED-1 ,Hector Battifora mesothelial-1 ,cytokeratin- 19,peroxisome proliferator-activated receptor-{gamma},and sodium/io- dide symporter antibodies for the differential diagnosis of non-medullar显示文摘 | Liu YY Morreau H Kievit J | 2008 | European Journal of Endocrinology2008，158，3： | 1 |
| 10 | Sialyl Lewis X expression and lymphatic mierovessel density in primary tumors of node negative colorectal cancer patients predict disease recurrence 显示文摘 | Doekhie FS Morreau H De Bock GH | 2008 | Cancer Microenviron2008，1，1： | 1 |
| 11 | Combined immunostaining with galeetin-3, fibroneetin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor- { gamma t , and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma显示文摘 | Liu YY Morreau H Kievit J | 2008 | Eur J Endocrinol2008，158，3： | 1 |
| 12 | Diagnostic approach and management of lynch syndrome ( hereditary nonpolyposis colorectal carcinoma) :a guide for clinicians显示文摘 | Hendriks YM de Jong AE Morreau H | 2006 | Cancer J Clin2006，56，4： | 1 |
| 13 | Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node - negative colorectal cancer patients predict disease recurrence显示文摘 | Doekhie FS Morreau H de Bock Gl-I | 2008 | Cancer Micro- environ2008，1，1： | 1 |
| 14 | New treatment modalities in advanced thyroid cancer显示文摘 | Kapiteijn E Schneider TC Morreau H | 2012 | Annals of Onenlogy2012，23，1： | 1 |
| 15 | Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma 显示文摘 | Hoftijzer H Heemstra KA Morreau H | 2009 | Eur J Endocri- nol2009，161，6： | 1 |
| 16 | Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma显示文摘 | HOFTIJZER H HEEMSTRA K A MORREAU H | 2009 | EurJ Endocrinol2009，161，6： | 1 |
| 17 | Expression and genomic profiling of colorectal cancer 显示文摘 | Cardoso J Boer J Morreau H | 2007 | Biochim Biophys Acta2007，1775，1： | 1 |
| 18 | Ten year review of intussuseeption at starship Hospilal: 1998-2007 显示文摘 | Kodikara H Lyrich A Morreau P | 2010 | N Z Ned J2010，123，1324： | 1 |
| 19 | Combined immunostaining with galectin-3, fibronectin-l, CITED-I, Hector Battifora mesotheli?al-I, cytokerann-Is, peroxisome proliferator-activated recep?tor-{garnma}, and sodium/iodide symporter antibodies for the differ?ential diagnosis of non-medullary thyroid carcinoma显示文摘 | Liu YY Morreau H Kievit J | 2008 | Eur J En?docrinol2008，158，： | 1 |
| 20 | Beneficial effects of sorafenib on tumor progression, but not on radioiodine up- take, in patients with differentiated thyroid earcinoma显示文摘 | Hoftijzer H Heemstra KA Morreau H | 2009 | Eur J Endo2009，161，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员